Quick Takeaways
- Paul A. Friedman filed SCHEDULE 13D/A for MADRIGAL PHARMACEUTICALS, INC. Common Stock, Par Value $0.0001 Per Share (MDGL).
- Disclosed ownership: 7.8%.
- Date of event: 10 Dec 2025.
Paul A. Friedman - 10 Dec 2025 SCHEDULE 13D/A Report for MADRIGAL PHARMACEUTICALS, INC. Common Stock, Par Value $0.0001 Per Share (MDGL)
- Filing Manager
- Paul A. Friedman
- Reporting Manager
- Paul A Friedman, M.D.
- Symbol
- MDGL
- Shares outstanding
- 23,267,064 shares
- Disclosed Ownership
- 1,814,831 shares
- Ownership
- 7.8%
- Form type
- SCHEDULE 13D/A
- Filing time
- 12 Dec 2025, 18:10:05 UTC
- Date of event
- 10 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Paul A. Friedman disclosed 7.8% ownership in MADRIGAL PHARMACEUTICALS, INC. Common Stock, Par Value $0.0001 Per Share (MDGL) on 10 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Dec 2025, 18:10.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Paul A Friedman, M.D. | 7.8% | 1,814,831 | 1,159,291 | 655,540 | /s/ Paul A. Friedman, M.D. | Paul A. Friedman, M.D. | 0001236927 |